News for GlaxoSmithKline plc (GSK)

[url="]Aldeyra Therapeutics, Inc.[/url] (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed t

Market Analysis by covering: Euro US Dollar, British Pound US Dollar, FTSE 100, Taylor Wimpey PLC. Read 's Market Analysis on Investing.com

**media[589978,589979]**

Omnicell, Inc. (Nasdaq: OMCL) (”œOmnicell” or the ”œCompany”), a leader in transforming the pharmacy and nursing care delivery model, today announced tha

On February 21, Jared Holz, Mizuho Securities America's healthcare sector strategist, appeared on CNBC to discuss Trump's tariffs and their effects on the American pharma sector.

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds.

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other pharmaceutical...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) f

e2Companies LLC, an innovative provider of integrated solutions for on-site power generation, distribution and energy cost-optimization, and Nabors Energy Tran

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health Organization on Monday, marking a dramatic acceleration of President Donald Trump's executive order to withdraw from the global health body.

**media[513326]**

Hindustan Unilever Ltd. made a payment of Rs 192.55 crore as part of a total outstanding tax demand of Rs 962.75 crore on Nov. 28, according to an exchange filing on Monday. The tax department had directed the company to make 20% payment of the total outstanding demand on or before Nov. 30, the filing stated. The demand was raised on "account of non-deduction of TDS" during a Rs 3,045-crore deal with GlaxoSmithKline Group entities.

Dan O’Day drives Gilead's mission to end HIV worldwide, pioneering treatments like lenacapavir and championing global health equity through bold access initiatives.

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (”œHUTCHMED” or the ”œCompany”) (Nasdaq/AIM:HC

**media[471196]**

GSK plc (NYSE:GSK) Guggenheim's Inaugural Healthcare Innovation Conference November 12, 2024 2:00 PM ETCompany ParticipantsEmma Walmsley - Chief Executive...

The Osteoporosis Treatment Market Size sector reached a market value of USD 10.74 Billion in 2018. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 4.4% from…

Another key driver of market increase is government campaigns and initiatives for the production and distribution of HPV vaccinations to stop the virus's...

Sickle Cell Disease Market Size Was Valued at USD 2.40 Billion in 2023, and is Projected to Reach USD 12.38 Billion by 2032, Growing at a CAGR of 20.00%...